Mainz Biomed partners with Quest for colorectal cancer screening test
Mainz Biomed has announced a partnership with Quest Diagnostics to support the commercialisation of its NextGen colorectal cancer screening test,…
Oncology
-
-
Karmanos Cancer Institute commences prescription of liver cancer device
The Barbara Ann Karmanos Cancer Institute, a part of McLaren Health Care, has commenced the prescription of a new radiofrequency…
-
Doherty and RMIT cancer screening blood test for leukaemia
Researchers from the Doherty Institute and Royal Melbourne Institute of Technology (RMIT) University have developed a new proof-of-concept blood test…
-
Natera begins subject enrolment in colon cancer detection test trial
Natera has begun the subject enrolment in the randomised Phase III SAGITTARIUS clinical trial designed to assess the Signatera test…
-
SamanTree Medical’s Histolog scanner shows promise in breast surgery outcomes
SamanTree Medical has revealed that its Histolog scanner, a confocal laser microscope, significantly decreased breast-conserving surgery (BCS) reoperation rates by…
-
NanoKnife gains FDA clearance for prostate tissue ablation
AngioDynamics has won US Food and Drug Administration (FDA) clearance for its NanoKnife system to be used in prostate cancer…
-
Adaptive unveils data of MRD assessment test in blood cancer treatment
Adaptive Biotechnologies has unveiled new data highlighting the significant role of measurable residual disease (MRD) assessment in the treatment of…
-
Reveal Genomics and IEO initiate breast cancer test impact study
Reveal Genomics and the Istituto Europeo di Oncologia (IEO) have initiated an impact study of the genomic test, HER2DX, to…
-
Lisata and Kuva Labs partner for MR imaging agents to detect cancer
Lisata Therapeutics and Kuva Labs have announced a worldwide partnership and licence agreement to develop a new class of advanced…
-
Delcath to trial Hepzato drug device combo in colorectal cancer
Delcath System has received clearance from the US Food and Drug Administration (FDA) for an investigational new drug (IND) application…
